TrialBritish journal of cancer2018

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

Ian Chau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.